Cost and Effectiveness of Therapy for Wet Age-Related Macular Degeneration in Routine Clinical Practice

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F13%3A10192264" target="_blank" >RIV/00216208:11110/13:10192264 - isvavai.cz</a>
Alternative codes found
RIV/00216224:14110/13:00069347 RIV/00216208:11150/13:10192264 RIV/65269705:_____/13:#0002128 RIV/00179906:_____/13:10192264 and 2 more
Result on the web
<a href="http://dx.doi.org/10.1159/000350802" target="_blank" >http://dx.doi.org/10.1159/000350802</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1159/000350802" target="_blank" >10.1159/000350802</a>

Result language
angličtina
Original language name
Cost and Effectiveness of Therapy for Wet Age-Related Macular Degeneration in Routine Clinical Practice
Original language description
Purpose: Evaluation of the cost and effectiveness of therapy for patients with the wet form of age-related macular degeneration (AMD) in routine clinical practice. Methods: A retrospective multicentre evaluation of changes in the best-corrected visual acuity in applied kinds of therapy and a comparison with the cost of individual therapeutic procedures. Results: An overall total of 788 eyes of 763 patients with an average age of 73.2 +/- 8.6 years was evaluated for a 1-year minimum period. In the ranibizumab and pegaptanib therapy groups, a reduction of 1.3 letters (p = 0.303) and 1.4 letters (p = 0.197) was found, respectively. In the group of photodynannic therapy (PDT) with verteporfin, a reduction of 5.2 letters was achieved (p < 0.001). Under theconditions of routine practice in the Czech Republic, the annual cost is highest (EUR 5,467.63/patient) in patients with pegaptanib therapy. The annual cost in patients with ranibizumab therapy is lower by EUR 1,220.16. The cost is nearly
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FF - ENT (ie. ear, nose, throat), ophthalmology, dentistry
OECD FORD branch
—

Publication year
2013
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical
Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift für Augenheilkunde
ISSN
0030-3755
e-ISSN
—
Volume of the periodical
230
Issue of the periodical within the volume
1
Country of publishing house
CH - SWITZERLAND
Number of pages
9
Pages from-to
34-42
UT code for WoS article
000321466100005
EID of the result in the Scopus database
—

Similar results(10)